| Post-stroke dysphagia: a review and design considerations for future trials DL Cohen, C Roffe, J Beavan, B Blackett, CA Fairfield, S Hamdy, ... International Journal of Stroke 11 (4), 399-411, 2016 | 475 | 2016 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 278 | 2019 |
| Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2 … D Wilson, G Ambler, C Shakeshaft, MM Brown, A Charidimou, ... The Lancet Neurology 17 (6), 539-547, 2018 | 248 | 2018 |
| The benefits of combined anti-platelet treatment in carotid artery stenting FM McKevitt, MS Randall, TJ Cleveland, PA Gaines, KT Tan, ... European journal of vascular and endovascular surgery 29 (5), 522-527, 2005 | 248 | 2005 |
| Stroke severity is a crucial predictor of outcome: an international prospective validation study NS Rost, A Bottle, JM Lee, M Randall, S Middleton, L Shaw, V Thijs, ... Journal of the American Heart Association 5 (1), e002433, 2016 | 225 | 2016 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 178 | 2018 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 177 | 2019 |
| Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies D Wilson, G Ambler, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 18 (7), 653-665, 2019 | 169 | 2019 |
| Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ... The Lancet 393 (10175), 1009-1020, 2019 | 159 | 2019 |
| Outcome of intracerebral hemorrhage associated with different oral anticoagulants D Wilson, DJ Seiffge, C Traenka, G Basir, JC Purrucker, T Rizos, ... Neurology 88 (18), 1693-1700, 2017 | 154 | 2017 |
| Cognitive screening in the acute stroke setting DJ Blackburn, L Bafadhel, M Randall, KA Harkness Age and ageing 42 (1), 113-116, 2013 | 140 | 2013 |
| Carotid Artery Stenosis: Accuracy of Noninvasive Tests—Individual Patient Data Meta-Analysis1 FM Chappell, JM Wardlaw, GR Young, JH Gillard, GH Roditi, B Yip, ... Radiology 251 (2), 493-502, 2009 | 115 | 2009 |
| Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a randomized controlled trial MS Randall, FM McKevitt, TJ Cleveland, PA Gaines, GS Venables Stroke 37 (2), 435-439, 2006 | 86 | 2006 |
| Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial T Fairbairn, I Kemp, A Young, C Ronayne, J Barton, J Crowe, L McQuade, ... Jama 327 (19), 1875-1887, 2022 | 84 | 2022 |
| Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART … RAS Salman, DP Minks, D Mitra, MA Rodrigues, P Bhatnagar, ... The Lancet Neurology 18 (7), 643-652, 2019 | 83 | 2019 |
| Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial IS Mackenzie, CJ Hawkey, I Ford, N Greenlaw, F Pigazzani, A Rogers, ... The Lancet 400 (10359), 1195-1205, 2022 | 81 | 2022 |
| Cognitive impairment before intracerebral hemorrhage is associated with cerebral amyloid angiopathy G Banerjee, D Wilson, G Ambler, K Osei-Bonsu Appiah, C Shakeshaft, ... Stroke 49 (1), 40-45, 2018 | 61 | 2018 |
| Prehospital transdermal glyceryl trinitrate for ultra-acute intracerebral hemorrhage: data from the RIGHT-2 trial PM Bath, LJ Woodhouse, K Krishnan, JP Appleton, CS Anderson, ... Stroke 50 (11), 3064-3071, 2019 | 47 | 2019 |
| Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or … JG Best, G Ambler, D Wilson, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 20 (4), 294-303, 2021 | 46 | 2021 |
| Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke G Mair, R von Kummer, Z Morris, A von Heijne, N Bradey, L Cala, ... Neurology 86 (2), 118-125, 2016 | 41 | 2016 |
Philip BathStroke Association Professor of Stroke Medicine, University of NottinghamVerified email at nottingham.ac.uk
